Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Bioventus, Inc.
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
August 07, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reports Second Quarter Financial Results
August 06, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
July 30, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reports First Quarter Financial Results
May 07, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
April 29, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
March 04, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
January 18, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
January 12, 2024
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Names Robert Claypoole as President and Chief Executive Officer
December 19, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
December 06, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
November 07, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Present at the Cantor Global Healthcare Conference
September 19, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
August 08, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
August 04, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
August 01, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Completes Divestiture of its Wound Business
May 23, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reports First Quarter Financial Results
May 16, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
May 15, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
May 11, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Announces Divestiture of its Wound Business
May 10, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
May 03, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Announces CEO Leadership Change
April 05, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
March 31, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
March 31, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
March 29, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023
March 16, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality – Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition
February 28, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
Bioventus, Inc.
Via
GlobeNewswire
Tickers
BVS
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.